Cargando…
Chronic myeloid leukemia‐derived extracellular vesicles increase Foxp3 level and suppressive activity of thymic regulatory T cells
Mechanisms driving immunosuppression in chronic myeloid leukemia are mostly unknown. We show that leukemic extracellular vesicles (EVs) target lymphocytes and amplify suppressive function of thymic regulatory T cells, by driving expression of Foxp3 transcription factor. This could facilitate expansi...
Autores principales: | Swatler, Julian, Dudka, Wioleta, Bugajski, Lukasz, Brewinska‐Olchowik, Marta, Kozlowska, Ewa, Piwocka, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187374/ https://www.ncbi.nlm.nih.gov/pubmed/31758697 http://dx.doi.org/10.1002/eji.201848051 |
Ejemplares similares
-
4-1BBL–containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells
por: Swatler, Julian, et al.
Publicado: (2022) -
Dysfunctional subsets of CD39+ T cells, distinct from PD-1+, driven by leukemic extracellular vesicles in myeloid leukemias
por: Swatler, Julian, et al.
Publicado: (2022) -
Immunosuppressive Cell Subsets and Factors in Myeloid Leukemias
por: Swatler, Julian, et al.
Publicado: (2021) -
Targeting integrated stress response with ISRIB combined with imatinib treatment attenuates RAS/RAF/MAPK and STAT5 signaling and eradicates chronic myeloid leukemia cells
por: Dudka, Wioleta, et al.
Publicado: (2022) -
Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection
por: Wiech, Milena, et al.
Publicado: (2022)